TrialBritish journal of cancer2019

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

Karin Ribi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.